Virological analysis of a regional mumps outbreak in the northern island of Japan-Mumps virus genotyping and clinical description

Japanese Journal of Infectious Diseases

Volumn 66, Issue 6, 2013, Pages 561-563

  Okajima, Kazuki ^a   Iseki, Kenichi ^a   Koyano, Shin ^b   Kato, Atsushi ^c   Azuma, Hiroshi ^b  

^a Fukagawa City General Hosp   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Deafness; Mumps; Outbreak; Sequel

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MUMPS VACCINE;

ANTIBODY TITER; ENZYME IMMUNOASSAY; EPIDEMIC; GENOTYPE; HEARING IMPAIRMENT; HERD IMMUNITY; HUMAN; INFECTION PREVENTION; JAPAN; MUMPS; MUMPS VIRUS; NONHUMAN; NOTE; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; PAROTITIS; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VACCINE FAILURE; VIRUS ENCEPHALITIS; VIRUS IDENTIFICATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ADOLESCENT; ADULT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; GENOTYPING TECHNIQUES; HUMANS; INFANT; JAPAN; MOLECULAR SEQUENCE DATA; MUMPS; MUMPS VIRUS; PHYLOGENY; YOUNG ADULT;

EID: 84888085109     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.66.561     Document Type: Note

References (27)

1. Rubin, S.A. and Carbone, K.M. (2011): Mumps. p. 1608-1610. In D.L. Longo, A.S. Fauci, D.L. Kasper, et al. (ed.), Harrison's Principles of Internal Medicine. 18th ed. McGraw-Hill, N.Y.
2. Vinagre, C., Martinez, M.J., Avendano, L.F., et al. (2003): Virology of infantile chronic recurrent parotitis in Santiago de Chile. J. Med. Virol., 70, 459-462.
3. Yoshida, N., Fujino, M., Miyata, A., et al. (2008): Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification. J. Med. Virol., 80, 517-523.
4. Chau, J.K., Lin, J.R., Atashband, S., et al. (2010): Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope, 120, 1011-1021.
5. Sawada, A., Yamaji, Y., Nakayama, T. (2013): Mumps Hoshino and Torii vaccine strains were distinguished from circulating wild strains. J. Infect. Chemother., 19, 480-485.
6. Baba, K., Okuno, Y., Tanaka-Taya, K., et al. (2011): Immunization coverage and natural infection rates of vaccine-preventable diseases among children by questionnaire survey in 2005 in Japan. Vaccine, 29, 3089-3092.
7. Takeuchi, K., Tanabayashi, K., Hishiyama, M., et al. (1991): Variations of nucleotide sequences and transcription of the SH gene among mumps virus strains. Virology, 181, 364-366.
8. Jin, L., Rima, B., Brown, D., et al. (2005): Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch. Virol., 150, 1903-1909.
9. Kidokoro, M., Tuul, R., Komase, K., et al. (2011): Characterization of mumps viruses circulating in Mongolia: identification of a novel cluster of genotype H. J. Clin. Microbiol., 49, 1917-1925.
10. Carr, M.J., Moss, E., Waters, A., et al. (2010): Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland. J. Clin. Microbiol., 48, 3288-3294.
11. Whelan, J., van Binnendijk, R., Greenland, K., et al. (2010): Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill., 15, pii=19554.
12. Centers for Disease Control and Prevention (CDC). (2010): Update: Mumps Outbreak-New York and New Jersey, June 2009-January 2010. MMWR Morb. Motal. Wkly. Rep., 59, 125-129.
13. Deeks, S.L., Lim, G.H., Simpson, M.A., et al. (2011): An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. Can. Med. Assoc. J., 183, 1014-1020.
14. Echevarria, J.E., Castellanos, A., Sanz, J.C., et al. (2010): Circulation of mumps virus genotypes in Spain from 1996 to 2007. J. Clin. Microbiol., 48, 1245-1254.
15. Uchida, K., Shinohara, M., Shimada, S., et al. (2001): Characterization of mumps virus isolated in Saitama prefecture, Japan, by sequence analysis of the SH gene. Microbiol. Immunol., 45, 851-855.
16. Inou, Y., Nakayama, T., Yoshida, N., et al. (2004): Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes. J. Med. Virol., 73, 97-104.
17. Lee, J.Y., Na, B.K., Kim, J.H., et al. (2004): Regional outbreak of mumps due to genotype H in Korea in 1999. J. Med. Virol., 73, 85-90.
18. Kaaijk, P., van der Zeijst, B.A., Boog, M.C., et al. (2008): Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype. Euro Surveill., 13, pii=18914.
19. Hviid, A., Rubin, S., Muä hlemann, K. (2008): Mumps. Lancet, 371, 932-944.
20. Asatryan, A., Pool, V., Chen, R.T., et al. (2008): Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990-2003. Vaccine, 26, 1166-1172.
21. Kawashima, Y., Ihara, K., Nakamura, M., et al. (2005): Epidemiological study of mumps deafness in Japan. Auris Nasus Larynx, 32, 125-128.
22. Nabe-Nielsen, J. and Walter, B. (1988): Unilateral deafness as a complication of the mumps, measles, and rubella vaccination. Brit. Med. J., 297, 489.
23. Kaga, K., Ichimura, K. and Ihara, M. (1998): Unilateral total loss of auditory and vestibular function as a complication of mumps vaccination. Int. J. Pediatr. Otorhinolaryngol., 43, 73-75.
24. Boga, J.A., de Onã a, M., Fernaá ndez-Verdugo, A., et al. (2008): Molecular identification of two genotypes of mumps virus causing two regional outbreaks in Asturias, Spain. J. Clin. Virol., 42, 425-428.
25. Noä jd, J., Tecle, T., Samuelsson, A., et al. (2001): Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine, 19, 1727-1731.
26. Rubin, S., Mauldin, J., Chumakov, K., et al. (2006): Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine, 24, 2662-2668.
27. Rubin, S.A., Qi, L., Audet, S.A., et al. (2008): Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J. Infect. Dis., 198, 508-515.